Last reviewed · How we verify
Parenteral administration of analgesics — Competitive Intelligence Brief
marketed
Analgesics (mixed class)
Pain Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Parenteral administration of analgesics (Parenteral administration of analgesics) — University Hospital Ostrava. Parenteral analgesics work by blocking pain signal transmission through various mechanisms including opioid receptor agonism, norepinephrine/serotonin reuptake inhibition, or direct nociceptive pathway modulation when administered via injection or infusion routes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Parenteral administration of analgesics TARGET | Parenteral administration of analgesics | University Hospital Ostrava | marketed | Analgesics (mixed class) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Analgesics (mixed class) class)
- University Hospital Ostrava · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Parenteral administration of analgesics CI watch — RSS
- Parenteral administration of analgesics CI watch — Atom
- Parenteral administration of analgesics CI watch — JSON
- Parenteral administration of analgesics alone — RSS
- Whole Analgesics (mixed class) class — RSS
Cite this brief
Drug Landscape (2026). Parenteral administration of analgesics — Competitive Intelligence Brief. https://druglandscape.com/ci/parenteral-administration-of-analgesics. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab